MY137089A - Materials and methods relating to protein aggregation in neurodegenerative disease - Google Patents
Materials and methods relating to protein aggregation in neurodegenerative diseaseInfo
- Publication number
- MY137089A MY137089A MYPI20032479A MY137089A MY 137089 A MY137089 A MY 137089A MY PI20032479 A MYPI20032479 A MY PI20032479A MY 137089 A MY137089 A MY 137089A
- Authority
- MY
- Malaysia
- Prior art keywords
- precursor protein
- fragment
- cell
- materials
- protein
- Prior art date
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
DISCLOSED ARE METHODS OF PROTEOLYTICALLY CONVERTING A PRECURSOR PROTEIN (E.G. TAU) TO A PRODUCT FRAGMENT (E.G. A 12 KD FRAGMENT) IN A STABLE CELL LINE, WHEREIN THE PRECURSOR PROTEIN IS ASSOCIATED WITH A DISEASE STATE IN WHICH THE PRECURSOR PROTEIN AGGREGATES PATHOLOGICALLY (E.G. A TAUOPATHY), AND THE METHODS COMPRISE: (A) PROVIDING A STABLE CELL LINE TRANSFECTED WITH NUCLEIC ACID ENCODING: (I) A TEMPLATE FRAGMENT OF THE PRECURSOR PROTEIN SUCH THAT THE TEMPLATE FRAGMENT IS CONSTITUTIVELY EXPRESSED IN THE CELL AT A LEVEL WHICH IS NOT TOXIC TO THE CELL; AND (II) THE PRECURSOR PROTEIN, WHICH PROTEIN IS INDUCIBLY EXPRESSED IN THE CELL IN RESPONSE TO A STIMULUS, WHEREBY INTERACTION OF THE TEMPLATE FRAGMENT WITH THE PRECURSOR PROTEIN CAUSES A CONFORMATIONAL CHANGE IN THE PRECURSOR PROTEIN SUCH AS TO CAUSE AGGREGATION AND PROTEOLYTIC PROCESSING OF THE PRECURSOR PROTEIN TO THE PRODUCT FRAGMENT. THE METHOD IS PREFERABLY USED TO SCREEN FOR MODULATORS OF THE AGGREGATION PROCESS BY MONITORING PRODUCTION (OR MODULATION OF PRODUCTION) OF THE PRODUCT BAND OR BANDS. ALSO PROVIDED ARE MATERIALS FOR USED IN THE ASSAYS, PLUS MEDICAMENTS, AND RELATED USES AND PROCESSES, BASED ON COMPOUNDS WHICH SHOW HIGH ACTIVITY IN THE ASSAY OF THE INVENTION E.G. REDUCED DIAMINOPHENOTHIAZINES.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI20032479 MY137089A (en) | 2003-07-01 | 2003-07-01 | Materials and methods relating to protein aggregation in neurodegenerative disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI20032479 MY137089A (en) | 2003-07-01 | 2003-07-01 | Materials and methods relating to protein aggregation in neurodegenerative disease |
Publications (1)
Publication Number | Publication Date |
---|---|
MY137089A true MY137089A (en) | 2008-12-31 |
Family
ID=45893945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI20032479 MY137089A (en) | 2003-07-01 | 2003-07-01 | Materials and methods relating to protein aggregation in neurodegenerative disease |
Country Status (1)
Country | Link |
---|---|
MY (1) | MY137089A (en) |
-
2003
- 2003-07-01 MY MYPI20032479 patent/MY137089A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1149588A1 (en) | Materials and methods relating to protein aggregation in neurodegenerative disease | |
DE50302840D1 (en) | PROCESS FOR THE PREPARATION OF ARYL-ARYL COUPLED COMPOUNDS | |
TR200201094T2 (en) | Bicyclic amino acids as pharmaceuticals | |
ATE334218T1 (en) | METHOD FOR THE SIMULTANEOUS PRODUCTION OF XYLITOL AND ETHANOL | |
WO2004058990A3 (en) | Genetic polymorphisms associated with stenosis, methods of detection and uses thereof | |
MXPA04006082A (en) | Malleable protein matrix and uses thereof. | |
DE50313162D1 (en) | INTEGRATED PROCESS FOR THE PREPARATION OF ISOCYANATES | |
DE69117949D1 (en) | PROTEIN ASSOCIATED WITH ACUTE PANCREATITIS, MEANS FOR DIAGNOSIS OF ACUTE PANCREATITIS | |
TW200505505A (en) | Process for modifying drug crystal formation | |
ATE260096T1 (en) | AGGLOMERATES BY CRYSTALIZATION | |
BRPI0416672A (en) | method of producing a lecithin-containing granular composition and lecithin-containing granular composition | |
ES2106772T3 (en) | PAI-2 VARIANTS. | |
ATE311476T1 (en) | POLYMORPHISMS IN THE HUMAN ORGANIC ANION TRANSPORTER C (OATP-C) GENE | |
MY137089A (en) | Materials and methods relating to protein aggregation in neurodegenerative disease | |
WO2003004681A3 (en) | Nucleic acid molecules encoding a transmembrane serine protease 20, the encoded polypeptides and methods based thereon | |
BR9913720A (en) | Purification process by crystallization or crystallization of carboxylic acids | |
ATE539051T1 (en) | METHOD FOR PRODUCING N-METHYL PYRROLIDONE USING GAMMA BUTYROLACTONE AND MIXED METHYLAMINES AS STARTING SUBSTANCES | |
ATE435291T1 (en) | ALLELES OF THE GLUCOCINASE GENE OF CORYNEFORM BACTERIA | |
MXPA05011157A (en) | A novel method of modulating bone-realted activity. | |
WO2004013122A3 (en) | Octupolar molecules used as organic semi-conductors | |
HUP9701747A2 (en) | Process for producing zeolites from raw materials containing alkaline-aluminium-hydrosilicate | |
TWI346654B (en) | Process for the purification of hexamethylenediamine | |
PL1664087T3 (en) | Prion clearance using particulate metal oxides | |
DE69919558D1 (en) | USE OF SOCS-2 OR CIS TO 'SCREEN' SUBSTANCES THAT ENHANCE A GROWTH HORMONE EFFECT | |
ATE180478T1 (en) | USE OF SUBSTITUTED 6-AMINO-4H-PYRANES |